Section 2095 - Quality Assurance(a) A veterinary premises that engages in compounding drug preparations shall establish a quality assurance program that documents and assesses medication errors to determine cause and an appropriate response.(b) The purpose of the quality assurance program shall be to assess errors that occur in the compounding of drug preparations, as well as to evaluate and document adverse reactions of animal patients to compounded drug preparations.(c) When a veterinarian determines that a medication error has occurred, the veterinarian shall immediately communicate to the client or the client's representative the fact that a medication error has occurred and the steps required to avoid injury or mitigate the error.(d) The Board may review records generated for and maintained as a component of the ongoing quality assurance program as necessary to protect the public health and safety or if fraud is alleged by a government agency with jurisdiction over the veterinary premises. Nothing in this section shall be construed to prohibit a client or client's representative from accessing records of the animal patient pursuant to subsection (b) of section 2032.3.(e) Reports of drug contraindications and adverse reactions may be included in the quality assurance documentation.Cal. Code Regs. Tit. 16, § 2095
1. New section filed 1-4-2022; operative 4-1-2022 (Register 2022, No. 1). (OAL review extended 60 calendar days pursuant to Executive Order N-40-20.) Note: Authority cited: Section 4826.5, Business and Professions Code. Reference: Section 4826.5, Business and Professions Code.
1. New section filed 1-4-2022; operative 4/1/2022 (Register 2022, No. 1). (OAL review extended 60 calendar days pursuant to Executive Order N-40-20.)